🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 31189P102
- Market Cap
- Mid Cap
- IPO
- 10/1/2013 · $6.00/share
Business: Fate Therapeutics, Inc. is a biopharmaceutical company dedicated to the development of programmed cellular immunotherapies. The Company's pipeline is comprised of cell-based therapies for cancer and immune disorders. Fate's cellular immunotherapies are based on its novel ex vivo cell programming approach, which they apply to modulate the therapeutic function and direct the fate of hematopoietic cells.
Company Contact
- CEO
- Scott Wolchko
- CFO
- Edward Dulac
- Headquarters
- 12278 Scripps Summit Drive, San Diego, CA 92131
- Phone
- 858-875-1800 · Toll-Free 866-875-1833
- Investor Relations
- Christina Tartaglia, Stern IR, Inc. · 212-362-1200 · christina@sternir.com